Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 49	$ 155
Receivables, net	1,276	1,152
Inventories	179	186
Other current assets	53	76
Total current assets	1,557	1,569
Equity method investments	472	433
Property, plant and equipment, net of accumulated depreciation, depletion and amortization of $26,420 and $25,914	17,303	17,213
Other noncurrent assets	336	360
Total assets	19,668	19,575
Current liabilities:
Accounts payable	1,514	1,364
Commercial paper	450	450
Payroll and benefits payable	40	70
Accrued taxes	135	126
Other current liabilities	310	312
Long-term debt due within one year	400	1,600
Total current liabilities	2,849	3,922
Long-term debt	4,578	3,378
Deferred tax liabilities	462	419
Defined benefit postretirement plan obligations	93	93
Asset retirement obligations	329	326
Deferred credits and other liabilities	213	232
Total liabilities	8,524	8,370
Commitments and contingencies (Note 17)
Stockholders’ Equity
Preferred stock – no shares issued or outstanding (no par value, 26 million shares authorized)	0	0
Common stock:
Issued – 937 million shares (par value $1 per share, 1.925 billion shares authorized at March 31, 2024 and December 31, 2023)	937	937
Held in treasury, at cost – 369 million shares and 360 million shares	(9,201)	(8,952)
Additional paid-in capital	7,129	7,172
Retained earnings	12,199	11,966
Accumulated other comprehensive income	80	82
Total stockholders’ equity	11,144	11,205
Total liabilities and stockholders’ equity	$ 19,668	$ 19,575